Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alveolitis, Fibrosing”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06853145
What this trial is testing

Hyperpolarized Xenon-129 MRI in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
University of Virginia 6
Early research (Phase 1)Active Not RecruitingNCT04262167
What this trial is testing

Human Autologous Lung Stem Cell Transplant for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis and Progressive Fibrotic Interstitial Lung Disease
University of North Carolina, Chapel Hill 24
Not applicableStudy completedNCT03420235
What this trial is testing

Home Monitoring in Idiopathic Pulmonary Fibrosis; Improving Use of Anti-fibrotic Medication and Quality of Life

Who this might be right for
Idiopathic Pulmonary Fibrosis
Erasmus Medical Center 90
Early research (Phase 1)Looking for participantsNCT07407543
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and Caucasian Adult Males

Who this might be right for
Idiopathic Pulmonary Fibrosis
siRNAgen Therapeutics Inc. 30
Not applicableStudy completedNCT03588260
What this trial is testing

Respiratory Muscle Strength in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Istanbul Medipol University Hospital 60
Not applicableLooking for participantsNCT06036719
What this trial is testing

Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives

Who this might be right for
Interstitial Lung Diseases
Institut National de la Santé Et de la Recherche Médicale, France 3,000
Early research (Phase 1)Study completedNCT05513950
What this trial is testing

Investigate the Safety, Tolerability, and Pharmacokinetics of Monoclonal Antibody (mAb) in Patients With IPF (SAD).

Who this might be right for
Idiopathic Pulmonary Fibrosis
Chiesi Farmaceutici S.p.A. 52
Early research (Phase 1)UnknownNCT05912049
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetic Properties and Immunogenicity of 9MW3811 in Healthy Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Mabwell (Shanghai) Bioscience Co., Ltd. 24
Not applicableStudy completedNCT01107028
What this trial is testing

Beneficial Effects of Pulmonary Rehabilitation for Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
National Jewish Health 41
Testing effectiveness (Phase 2)Active Not RecruitingNCT05570058
What this trial is testing

Assess the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of RXC007 in Idiopathic Pulmonary Fibrosis

Who this might be right for
IPFFibrosis
Redx Pharma Ltd 48
Testing effectiveness (Phase 2)Ended earlyNCT00703339
What this trial is testing

Effects of Inhaled Treprostinil Sodium for the Treatment of Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary FibrosisPulmonary Hypertension
Lung Biotechnology PBC 1
Early research (Phase 1)UnknownNCT06482190
What this trial is testing

Evaluate Safety, Tolerability and Pharmacokinetics of RSN0402 in Healthy Volunteers

Who this might be right for
Idiopathic Pulmonary FibrosisLung; Disease, Interstitial, With Fibrosis
Shenzhen Resproly Biopharmaceutical Co., Ltd 72
Testing effectiveness (Phase 2)Looking for participantsNCT03500731
What this trial is testing

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Who this might be right for
Idiopathic Pulmonary FibrosisEmphysema or COPD
Paul Szabolcs 8
Testing effectiveness (Phase 2)Ended earlyNCT03573505
What this trial is testing

An Efficacy and Safety Study of BG00011 in Participants With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Biogen 109
Large-scale testing (Phase 3)Study completedNCT02460588
What this trial is testing

Cyclophosphamide for Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Assistance Publique - Hôpitaux de Paris 120
Early research (Phase 1)Study completedNCT03981094
What this trial is testing

The Pharmacokinetic Interaction Between Pirfenidone and BMS-986278 in Healthy Participants

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Bristol-Myers Squibb 22
Testing effectiveness (Phase 2)Looking for participantsNCT06747923
What this trial is testing

SB17170 Phase 2 Trial in IPF Patients

Who this might be right for
IPFIdiopathic Pulmonary FibrosisIdiopathic Pulmonary Fibrosis (IPF)
SPARK Biopharma 30
Early research (Phase 1)Study completedNCT04512170
What this trial is testing

Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects

Who this might be right for
Idiopathic Pulmonary Fibrosis
Sunshine Lake Pharma Co., Ltd. 72
Not applicableStudy completedNCT03901196
What this trial is testing

Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)

Who this might be right for
Interstitial Lung DiseaseSarcoidosisIdiopathic Pulmonary Fibrosis
University Hospital, Grenoble 86
Early research (Phase 1)Study completedNCT02478268
What this trial is testing

Using MRI to Visualize Regional Therapy Response in Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis
Bastiaan Driehuys 64
Next Page